Month: November 2016

Blue Horseshoe Stocks: Options Success, MNKD & More

Eleven BioTherapeutics, Inc. EBIO

Out of four focal points for yesterday morning’s premarket report, three of them worked out very nicely. From the stock side of things, we had EBIO, which we designated as a potential momentum play after noticing it picking up steam in prior sessions.

Our hunch was good, as the stock ran from a low of 2.31 to 2.955 (+28%) on roughly nine times its monthly average volume. It was a relatively modest gain, yet we did see a temporary breach of the 50DMA as well as a strong close at 2.78. It was a solid enough performance to warrant further observation.

______

MannKind Corp. MNKD – We drew attention to MNKD on Wednesday morning and just want to provide an update on its excellent progress so far. In the past two sessions since then it has traded up from a low of .44 to .68 (+55%) in two bullish sessions. We’ll be looking for a possible continuation of that trend.

Options Winners

The other two winners from yesterday were both successful options ideas that we formulated on the heels of strong earnings reports, and the gain opportunities there were quite a bit larger.

We’ve come to routinely expect huge multi-bag intraday runs when we hit on a good post-earnings idea, and that’s just what we got from every single contract we signaled.

Macy’s, Inc. M – Weekly $38-41 Calls

$38 Calls – Range: 1.52-3.85 – Max Gain: 153%
$38.50 Calls – Range: 1.27-2.90 – Max Gain: 128%
$39 Calls – Range: 1.00-2.97 – Max Gain: 191%
$39.50 Calls – Range: .81-2.25 – Max Gain: 178%
$40 Calls – Range: .50-1.90 – Max Gain: 280%
$40.50 Calls – Range: .30-1.47 – Max Gain: 390%
$41 Calls – Range: .15-1.16 – Max Gain: 673%

Shake Shack, Inc. SHAK – Weekly $35.50-37 Calls

$35.50 Calls – Range: .39-2.00 – Max Gain: 413%
$36 Calls – Range: .37-2.62 – Max Gain: 609%
$36.50 Calls – Range: .35-.77 – Max Gain: 120%
$37 Calls – Range: .18-1.90 – Max Gain: 956%

______

Fresh Idea – Nvidia Corp. NVDA – Nvidia beat on earnings in a post-market release yesterday, and to correspond with the activity we’re observing here in the premarket, we want to highlight the NVDA Weekly $77-80 Calls* for potential daytrades.

*Our regular readers are well aware of the warnings we post every time we issue an alert, but for everyone just joining us, please be aware that trading options contracts with a weekly expiration on a Friday is a highly risky proposition, and should only be undertaken by expert traders!

Extended Watchlist:
CHMD, DNRG, FNMA, FMCC, LLEN, SRCH,
DXYN(Bottom-Watch)

Blue Horseshoe Stocks: CCTC, EBIO, Options & More


Potential Momentum Plays

Clean Coal Technologies, Inc. CCTC – In a characteristic move, CCTC repeated the history of its own chart, as a stock that seemingly likes to make volatile swings to the upside. It breached its 50DMA in a bullish manner yesterday, so we are going to tag it for observation today in the event of continued momentum.

The chart is showing a series of ripening indicators as well. In order to hold our attention, CCTC will need to maintain support at or above that 50DMA, currently at .153 on any pullbacks.


______

Eleven BioTherapeutics, Inc. EBIO – EBIO is a stock we’ve come back to on several occasions in the past, and today, we want to circle around to point out its current status as a bottom-bouncing momentum play.

It hit four-month lows just five sessions ago, and has made a decent effort at a rebound since then, so we’ll keep it on watch for the possibility of further recovery.

Options Ideas

We’ve got a couple of earnings-related options ideas this morning as well. As our regular readers are surely aware, post-earnings options trading is one of our favorite and most reliable ways of rooting out rapid short term gain opportunities.

Shake Shack, Inc. SHAK – Weekly $35.50-37 Calls

Macy’s, Inc. M – Weekly $38-41 Calls

______

Reminder: We’re also still tracking our idea on Starbucks from last Friday, the SBUX Weekly $53.50-55 Calls. The stock has traded up to nearly $55 in the premarket today, so we’ll be open to the possibility of seeing our gains extended there.

Extended Watchlist:
PXYN, LGBI, PARS, IFAN, CAFS, NNLX, KBS, FCEL

Blue Horseshoe Stocks: Major Victory for Marijuana & More

Starbucks Corp. SBUX – Options Update

Our options idea from Friday morning, the SBUX 11/11 $53.50-55 Calls
continued to be good plays as SBUX stock posted some solid intraday activity even as many others faltered in the uncertainty of the elections. It allotted for us to see further opportunities over the multi-bag gains we’d already been afforded to that point.

$53.50 Calls – Range: 1.05-1.47 – Max Gain: 169%
$54 Calls – Range: .76-1.07 – Max Gain: 300%
$54.50 Calls – Range: .45-.69 – Max Gain: 458%
$55 Calls – Range: .23-.43 – Max Gain: 344%

The markets as a whole are showing trepidation over the events of the past 24 hours, but once again, we must remain open to the possibility of seeing further moves out of these contracts which have treated us well so far.

CANNABIS SECTOR UPDATE:

As expected California passed its recreational marijuana initiative on election day, with Nevada and Massachusetts following suit.  Medical pot passed in North Dakota, Arkansas, and Florida. As we stated before, the whole landscape of the cannabis industry is set to change now, as the country as a whole takes several leaps toward the end of nationwide prohibition.

It’s just the outcome we expected, and the ramifications will begin to come into clearer focus in the weeks and months ahead as we observe how each state will handle roll-out of the new laws.

Our sector-wide alert will continue indefinitely as the effects of the outcomes on the investment side of things materialize.

Potential Bottom Plays

MannKind Corp. MNKD – It’s been a long while since we’ve taken a look at MNKD, and we want to draw some attention to it this morning as a possible bottom play. It’s been in a general downtrend for the better part of four months, and looks like it could be in a good spot for a rebound from this juncture. We’ll reserve it a space on our radar moving forward.

Teva Pharmaceutical Industries Ltd. TEVA – The threat of a class-action lawsuit has produced a backslide in TEVA in recent sessions. It’s just the kind of consolidation on non-material developments that we’re always scanning for as course corrections can often occur following this type of activity, and sure enough, the stock appears to be rebounding in the premarket. To take advantage, we’re going to look to the TEVA Weekly $40.50-42.50 Calls.

Extended Watchlist:
UAMM, AGTK, REFG, CBGI, WSGF, DAKP